valine has been researched along with mdl 100453 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, BM; Chi, EM; Harrison, BL; Kehne, JH; McCloskey, TC; Palfreyman, MG; Whitten, JP | 1 |
| Baron, BM; McDonald, IA; Miller, F; Muench, D; White, HS; Whitten, JP | 1 |
| Baron, BM; Fisher, M; Hasegawa, Y; Metcalf, G | 1 |
| Baron, BM; Chopp, M; Jiang, N; Zhang, RL | 1 |
| Baron, BM; Chen, TM; Cornelius, KE; Fadayel, GM; Haegele, KD; Schmidt, CJ | 1 |
| Bickers, MV; Braun, DL; Johnson, MP; Markgraf, CG | 1 |
| Blanchet, PJ; Chase, TN; Konitsiotis, S; Whittemore, ER; Woodward, RM; Zhou, ZL | 1 |
7 other study(ies) available for valine and mdl 100453
| Article | Year |
|---|---|
NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Anxiety Agents; Anxiety, Separation; Behavior, Animal; Buspirone; Diazepam; Dioxins; Dizocilpine Maleate; Dose-Response Relationship, Drug; Indoles; Kynurenic Acid; Maternal Deprivation; Mephenesin; Piperidines; Quinolizines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Serotonin Antagonists; Spiro Compounds; Valine; Vocalization, Animal | 1991 |
(R)-4-oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex.
Topics: Animals; Binding, Competitive; Cerebellum; Cyclic GMP; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Kindling, Neurologic; Mice; Mice, Inbred DBA; N-Methylaspartate; Rats; Receptors, N-Methyl-D-Aspartate; Valine | 1990 |
The competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke.
Topics: Animals; Blood Pressure; Body Temperature; Brain; Carbon Dioxide; Cerebral Arteries; Cerebral Infarction; Infusion Pumps; Injections, Intravenous; Ischemic Attack, Transient; Male; N-Methylaspartate; Pilot Projects; Placebos; Rats; Rats, Sprague-Dawley; Valine | 1994 |
Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.
Topics: Animals; Arterial Occlusive Diseases; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Infusions, Intravenous; Male; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Valine | 1996 |
Analysis of (R)-4-oxo-5-phosphononorvaline (MDL 100,453) in rat plasma and brain dialysate using liquid chromatography after derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate.
Topics: Aminoquinolines; Animals; Brain Chemistry; Carbamates; Chromatography, High Pressure Liquid; Dialysis; Excitatory Amino Acid Antagonists; Indicators and Reagents; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Reference Standards; Spectrometry, Fluorescence; Valine | 1995 |
Behavioral recovery patterns in rats receiving the NMDA receptor antagonist MDL 100,453 immediately post-stroke.
Topics: Animals; Arterial Occlusive Diseases; Behavior, Animal; Cerebral Arteries; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Grooming; Male; Maze Learning; Neuroprotective Agents; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Time Factors; Valine | 1997 |
Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
Topics: Animals; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Oocytes; Parkinson Disease, Secondary; Rats; Receptors, N-Methyl-D-Aspartate; Valine; Xenopus laevis | 1999 |